August 28, 2016 2:03 AM ET

Biotechnology

Company Overview of Ardea Biosciences, Inc.

Key Executives for Ardea Biosciences, Inc.

NameBoard RelationshipsTitleAge
James Mackay Ph.D.34 RelationshipsPresident and Chief Operating Officer--
John W. Beck CPANo RelationshipsChief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance & Operations56
Kimberly J. Manhard No RelationshipsSenior Vice President of Regulatory Affairs & Development Operations56
Colin E. Rowlings Ph.d.No RelationshipsSenior Vice President of Pharmaceutical Sciences52

Ardea Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin C. Tang 26 RelationshipsTang Capital Management, LLC49
John W. Poyhonen MBA 28 RelationshipsSenomyx Inc.56
David D. Ho M.D. 67 RelationshipsTaiMed Biologics Inc.--
Craig A. Johnson 48 RelationshipsLa Jolla Pharmaceutical Co.54
Barry D. Quart Pharm.D. 20 RelationshipsHeron Therapeutics, Inc.59
View All Board Members

Ardea Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Craig A. Johnson48 Relationships2 Executives
Compensation Committee MBAJohn W. Poyhonen28 Relationships3 Executives
Nominating Committee Kevin C. Tang26 Relationships2 Executives
Corporate Governance Committee Kevin C. Tang26 Relationships2 Executives
Advisory Board M.D.David D. Ho67 Relationships11 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
379.7K
Bonus
264.9K
Total Short Term Compensation
476.9K
Total Value of Options
33.9M
Compensation as of Fiscal Year
Ardea Biosciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

OncoCyte Corporation Announces the Resignation of Dr. Michael D. West from Board of Directors
August 19, 2016 8:57 PM ET
Enumeral Biomedical Holdings, Inc. Announces the Resignation of Anhco Nguyen, Ph.D. as Vice President of Research and Development
August 19, 2016 8:30 PM ET
David A. Berry Notifies Eleven Biotherapeutics, Inc. of His Resignation as Member of the Board of Directors and the Compensation Committee
August 19, 2016 8:12 PM ET
Applied Genetic Technologies Corporation Appoints Anne M. VanLent to the Board of Directors
August 18, 2016 8:01 PM ET
Organovo Holdings, Inc. Announces Board Appointments
August 18, 2016 12:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ardea Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.